Renan Ozyerli, MD, MSD Turkey
Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the…
MSD Turkey
Last updated: 27.07.2015
MSD entered the Turkish pharma market in 1989 and established a subsidiary in 1993.
The headquarters are based in Istanbul. MSD employs 463 people in Human Health, as well as 32 people in Animal Health. Products are sourced from the global MSD network and toll manufacturing from 4 local companies. The subsidiary has a fully operational warehouse.
Currently, MSD Turkey is participating in 23 international clinical trials at 113 study centers. As such, the affiliate ranks among the top 3 research-based pharma companies in terms of clinical research capability. MSD Turkey also houses the management oversight/responsibility of Middle East and Egypt with 6 trials and 21 study centers in 5 different countries. In 2014, Merck HQ funded TRY 20.7 million (USD 9.5 million) to Turkey for clinical trials.
Contact Details
Merck Sharp Dohme İlaçları Ltd. Şti.
Esentepe Mah. Büyükdere Cad. No: 199
Levent 199 Ofis Bloğu Kat: 13, 34394 Levent-İstanbul
Tel:+90 212 336 1000
Fax:+90 212 215 2733
http://www.msd.com.tr/
Interviews
Interview: Hatice Demiray – Managing Director, MSD Turkey
MSD Turkey has benefited in recent years from the ability to engage in local business development initiatives, and…
Related
SeokHoon Kang – General Manager Turkey, Celltrion Healthcare
Best known as the company that launched the world’s first “antibody biosimilar,” Celltrion is looking to…
Evren Özlu – General Manager, Boehringer Ingelheim Turkey
Evren Özlü, General Manager of Turkey and Sub-Saharan Africa at Boehringer Ingelheim, discusses the company’s…
Ufuk Kumrulu – Chairman, Polifarma
Polifarma is a Turkish pharma company dedicated to the hospital sector and biosimilars. Its chairman, Ufuk Kumrulu,…
Turkey / A Pharma Talent Hotbed
Drawing on over a dozen interviews with C-level pharmaceutical industry executives in Turkey, PharmaBoardroom has…
Burak Dağlıoğlu – President, Investment Office of the Presidency of the…
The president of the Investment Office of the Presidency of the Republic of Turkey, Burak Dağlıoğlu, outlines…
Muzzafer Bal – CEO, Ali Raif
Muzaffer Bal, CEO of Ali Raif, a Turkish generics firm, highlights the company’s new investment in a…
Turkey / Abdi Ibrahim CEO Talks Biosimilars, M&A, & US Entry
Süha Taşpolatoğlu, CEO of Abdi Ibrahim, Turkish pharma’s “national champion”, discusses the company’s…
Hatice Öncel – CEO, Ilko Pharmaceuticals
Ilko Pharmaceuticals is a family-owned Turkish generics and biosimilars company. General Manager Hatice Öncel…
Hamdi Akan – Head of the Executive Board, Clinical Research Association,…
Dr Hamdi Akan, head of Turkey’s Clinical Research Association, dives into the country’s opportunities and…
Ismail Yormaz – VP & Regional Director South-East, Recordati
Ismail Yormaz, Recordati’s VP and regional director for south-east, highlights how the Milan-based company has…
Turkey / How Pricing is Straining Turkish Pharma’s Sustainability
Almost two decades after initiating large-scale health system reforms, Turkey has consolidated the provision of…
Şeyda Atadan Memiş – General Manager, Takeda Turkey
Takeda’s general manager for Turkey, Şeyda Atadan Memiş, reflects on the Japanese giant’s ambitions in Turkey…
